Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2009; 15(22): 2754-2762
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2754
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2754
Figure 1 EphA-2 expression in human cell lines.
A: Analysis of EphA2R expression by Western blotting in human umbilical vein endothelial cells (Hu), human pancreatic cancer cell lines BxPc-3 (Bx), Hs766-T (Hs), Capan-1 (Ca), MIA PaCa-2 (Mia), p6.3, p10.5 and human fibroblasts (Fi). EphA2R was detected using a monoclonal antibody and detection of actin levels was performed as a loading control; B: Immunolocalization of EphA2R in human pancreatic cancer cell lines BxPc-3 (left top), Capan-1 (right top), Hs766-T (bottom left), MiaPaca-2 (bottom right). Cells were fixated with methanol, acetone, and water, and a directed monoclonal antibody was used to detect EphA2R using a goat anti-mouse labeled with PO to perform DAB detection. Magnification (× 600), except for MiaPaca-2 (× 400).
-
Citation: van Geer MA, Bakker CT, Koizumi N, Mizuguchi H, Wesseling JG, Oude Elferink RP, Bosma PJ. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction
in vivo . World J Gastroenterol 2009; 15(22): 2754-2762 - URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2754.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2754